The company Tempus is seeking FDA clearance for its technology and listed on the NASDAQ stock exchange.
2 reports, 2 independent
Updated Sep 1
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The company Tempus is seeking FDA clearance for its technology and listed on the NASDAQ stock exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Tempus
biotechnology company based in Chicago, Illinois
- FDA
-
Nasdaq
American fully electronic stock exchange